seed
Stage
1
Investors
About
Epigenica develops multiplexed chromatin profiling technology that enables simultaneous, high-throughput, and quantitative analysis of multiple epigenetic marks such as DNA methylation and histone modifications from low input biological samples to support biomedical research and precision medicine.
Explore Epigenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.